Related Experiment Video

Updated: May 4, 2026

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.7K

Is Radiographic Aftercare Obsolete? How Testing Positive for ctDNA Can Be a Precedent for Late Relapse, Even in

Kerstin Pfister1, Sophia Huesmann1, Angelina Fink1

  • 1Department of Gynecology and Obstetrics, University Hospital Ulm, 89075 Ulm, Germany.

International Journal of Molecular Sciences
|September 13, 2025
PubMed
Summary

Circulating tumor DNA (ctDNA) detection in low-risk breast cancer patients may precede clinical relapse by years. This case highlights ctDNA

Keywords:
MRDbreast cancerctDNAliquid biopsymolecular relapse

More Related Videos

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.1K
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

7.0K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K